|
|
|
Committee on
Energy and Commerce
2125 Rayburn House Office
Building, Washington, DC
20515
Phone: (202) 225-2927 Contact Us »
Home »
|
|
|
Home Page > The 110th Congress Public Record > By Subject > Oversight and Investigations |
OVERSIGHT & INVESTIGATIONS
The Public Record for the 110th Congress
This is a list of public information regarding oversight and investigations released in the 110th Congress by the Committee on Energy and Commerce. The information is listed by date. If you require information that was available on this Web site for a previous Congress, please see the archives page.
» News Releases |
|
» Letters |
|
» Statements |
|
» Reports |
|
September 8, 2008 |
Dingell, Stupak on Administration’s Withdrawal of Russian Nuclear Agreement |
August 22, 2008 |
Dingell, Stupak Applaud FDA’s Approval of Irradiation on Lettuce & Spinach; After Eight Years, FDA Finally Acts on Petition to Help Prevent Foodborne Illness |
August 21, 2008 |
Dingell, Stupak Question Drug Makers on Safety of Vytorin and Conflicting Study Data; Recent Study Links Vytorin to Increased Cancer Risk
|
August 11, 2008 |
Dingell, Stupak Ask for GAO Report on Highly Enriched Uranium |
August 5, 2008
|
Dingell, Stupak Applaud FDA for ESA Label Change
|
July 28, 2008
|
Committee Leaders Release CRS Report Showing DOE’s Counterintelligence Program May Be Off Course
Read the CRS Report » |
July 23, 2008
|
Senate, House Members Release Results of GAO Report on Long-Term Care Insurance
Read the GAO Report » |
July 22, 2008
|
Dingell, Stupak to Investigate Ranbaxy Drug Approvals
|
July 22, 2008
|
Dingell, Stupak Comment on Results of New Vytorin Study
|
July 21, 2008
|
Dingell, Stupak Comment on Latest Developments in FDA Salmonella Investigation |
July 17, 2008
|
Dingell, Stupak Question Whether FDA Knowingly Allowed Potentially Unsafe & Ineffective Drugs into the U.S. Marketplace
Read the Motion » |
July 15, 2008
|
GAO Report Finds Los Alamos Security Problems Still Not Fully Addressed
Read the GAO Report » |
July 9, 2008
|
Dingell, Stupak Comment on Beef Recall |
July 2, 2008
|
Dingell, Stupak Continue Food Safety Investigation as FDA Struggles to Pinpoint Source of Salmonella Outbreak |
June 26, 2008
|
Dingell on FDA Bonuses
|
June 25, 2008
|
Lawmakers Call for GAO Probe of Security at Lawrence Livermore Nuclear Lab
|
June 16, 2008
|
Dingell, Stupak Welcome PhRMA Invitation to Discuss DTC Regulations
|
June 10, 2008
|
Dingell on Administration’s Budget Request for FDA
|
June 5, 2008
|
Committee to Hold Legislative Hearings on Climate Change Proposals
|
May 23, 2008
|
Committee Questions Homeland Security Plans to Move Animal Disease Research Facility to U.S. Mainland
|
May 23, 2008
|
Dingell, Stupak Request GAO Probe State Department’s Assessment of Russian Nuclear Pact
|
May 22, 2008
|
Government Accountability Office Report Raises Red Flags on DOE Nuclear Waste Reprocessing Program
|
May 20, 2008
|
Dingell, Stupak Request Improved Accuracy, Stronger Guidelines for DTC Ads
|
May 15, 2008
|
Committee Probes Nursing Home Quality Issues
|
May 14, 2008
|
Dingell on Russian Nuclear Pact Being Sent to Congress
|
May 8, 2008
|
Dingell, Stupak ask Multinational Food Processors about Contamination
|
May 7, 2008
|
Dingell, Stupak to President: Address Proliferation Concerns before Sending Russian Nuclear Pact to Congress
|
May 6 , 2008
|
Dingell, Stupak Call on Infant Formula Manufacturers to Remove Bisphenol A from Packaging
read the letters »
|
May 6 , 2008
|
Dingell, Stupak Move to Expose Purveyors of Adulterated Food
read the letters »
|
April 30, 2008
|
Dingell, Stupak on Public Comment Draft of CDC Great Lakes Report
|
April 22, 2008
|
Dingell, Stupak Respond to FDA’s Announcement on Heparin
|
April 18, 2008
|
Dingell, Stupak Praise Nalgene and Wal-Mart Canada for Discontinuing Use of Bisphenol A
|
April 17, 2008 |
Energy and Commerce Committee Seeks Probe of Hanford Nuclear Waste Site |
April 11, 2008
|
After Review of ENHANCE Trial Documents, Dingell, Stupak Express “Serious Concerns”
Read the Letter »
Read the Attachments » |
April 8, 2008 |
Committee Probe Finds FDA Used Industry Studies to Approve Chemical in Infant Formula Liners
read the letter » |
April 2, 2008 |
Dingell, Stupak Investigate American Chemistry Council, EPA Review Panels
read the letter »
|
April 1, 2008 |
Dingell, Stupak Continue Investigations into DTC Advertising and ESA Safety
read the letter to Johnson & Johnson »
read the letter to Amgen » |
April 1, 2008 |
Jump in Uranium Prices Provides $7.6 billion potential windfall to Energy Department
read the report » |
March 27, 2008 |
Dingell, Stupak Move to Protect Great Lakes Report Whistleblower
read the letter » |
March 24, 2008 |
Committee to Probe Breakdowns in NIH Security |
March 19, 2008 |
Committee Panel to Hold Hearings on Heparin Failures
read the letter » |
March 13, 2008 |
Dingell on Release of CDC Great Lakes Report
|
March 11, 2008 |
Dingell, Stupak Continue ‘Science for Sale’ Probe Request Consulting Firm Case Studies
|
March 7, 2008 |
Committee Leaders Commend New Commerce IG for Restoring Whistleblower Jobs
read the letter » |
March 5, 2008 |
Energy and Commerce Committee Subpoenas Hallmark/Westland Chief |
February 28, 2008 |
Energy and Commerce Leaders Investigate Cover-Up of Great Lakes Report
read the Report »
read the Letter »
|
February 25, 2008 |
How Much Will it Cost to Adequately Fund FDA’s Core Programs? Energy & Commerce Leaders Release Recommendations of Former Members and Advisors to FDA’s Science Advisory Board
|
February 25, 2008 |
Dingell, Stupak Comment on Pfizer Decision to Pull Lipitor Ads Featuring Dr. Jarvik
|
February 21, 2008 |
Dingell, Stupak Consider Changing Law Over Heparin Failures
Read the Letters:
Letter to FDA Commissioner von Eschenbach »
Letter to HHS Secretary Leavitt »
Letter to Baxter International Inc. » |
February 7, 2008 |
Committee Continues Investigation into Celebrity Drug Endorsements |
February 6, 2008 |
Department of Energy Program Funds Russian Nuclear Work in Iran |
February 6, 2008 |
Congressional Bisphenol A Probe Widens to
Examine Consulting Group |
February 5, 2008 |
Dingell, Stupak Comment on FDA Revitalization Plan |
January 31, 2008 |
Dingell, Stupak Comment on FDA Decision to Retain Field Labs |
January 29, 2008 |
Energy and Commerce Subcommittee Subpoenas FDA Witnesses, Documents |
January 25, 2008 |
Dingell, Stupak Comment on FDA Plan for Overseas Inspections |
January 24, 2008 |
Dingell, Stupak Question Merck/Schering-Plough’s Sponsorship of American College of Cardiology and American Heart Association |
January 23, 2008 |
Dingell, Stupak Comment on Decision to Pull Vytorin Ads |
January 22, 2008 |
Dingell, Stupak Continue ENHANCE Trial Inquiry |
January 17, 2008 |
Committee to Investigate Chemical in Infant Formula Liners
read the Letters » |
January 16, 2008 |
Dingell, Stupak Raise Concerns, Questions on
ENHANCE Trial |
January 11, 2008 |
Thompson Releases Report on Russian WMD Scientists
GAO report » |
January 9, 2008 |
GAO Calls for Added Port Security with Projected Growth in Liquified Natural Gas Imports |
January 7, 2008 |
Energy and Commerce Committee to Probe Breakdowns in NRC Oversight |
December 20, 2007 |
Dingell, Stupak Applaud Grassley’s Ketek Investigation,Announce Additional Hearings |
December 13, 2007 |
Dingell, Stupak Investigating Institutional Review Boards, Questionable Medical Devices |
December 12, 2007 |
House Energy and Commerce Committee Holds Hearing on Energy Market Manipulation |
December 7, 2007 |
Dingell, Stupak Question EPA on “Fishbowl” Transparency Policy |
December 3, 2007 |
Dingell Announces Inquiry by Subcommittee on Oversight and Investigations into Transparency of FCC Regulatory Process |
November 9, 2007 |
5 Years Later, White House Still Hasn’t Implemented Law to Protect Americans Near Nuclear Plants; House Energy and Commerce Committee Announces Investigation |
November 2, 2007 |
Dingell, Stupak Request Information, Urge Agencies to Address Weaknesses with Radiation Detection Equipment |
October 25, 2007 |
Dingell, Stupak Respond to DOJ’s Announcement of Record Penalties Against BP |
October 25, 2007 |
Dingell, Stupak Assert that FDA Letter to Sanofi-Aventis Vindicates Whistleblowers; “Warning Letter” Shows FDA Knew Ketek Safety Study Was Compromised |
October 24, 2007 |
Dingell, Stupak Respond to BP Price-Fixing Settlement |
October 16, 2007 |
Dingell, Stupak Praise Giant, Stop & Shop for Ceasing Sale of Meat Treated with Carbon Monoxide |
October 10, 2007 |
Subcommittee on Telecommunications and the Internet Approves 911 Safety, Broadband Mapping Legislation; Bills to Ensure 911 Access for VoIP Providers, Obtain Accurate Data on Nationwide Broadband Availability |
October 4, 2007 |
Dingell, Stupak Release Report on Safety of Food Imported from China; Announce Series of Hearings
view the Report » |
October 3, 2007 |
Committee Requests CDC Records on the Use of Antibiotics in Animals |
October 2, 2007 |
Committee Opens Investigation into Warrantless Wiretapping; Dingell, Markey, Stupak Request Information from Phone Companies,Consumer Privacy Advocate Groups |
October 2, 2007 |
Stupak, Dingell Applaud Energy Department Decision to Reject $9.5 billion Sole Source Contract Proposal from Energy Solutions and USEC
September 20, 2007 DOE letter » |
September 21, 2007 |
Dingell, Stupak Announce Date for Hearing on Biosafety Labs; Recent Incidents Underscore Risks Associated with Labs |
September 20, 2007 |
Dingell Introduces H.R. 3610, the “Food and Drug Import Safety Act of 2007” |
September 18, 2007 |
Dingell on Grocery Manufacturers Association Food Safety Action Plan |
September 18, 2007 |
Committee Assails Administration Plans to Certify New Radiation Portal Monitors Before Machines are Adequately Tested |
September 10, 2007 |
Dingell Responds to Import Safety Report |
September 4, 2007 |
Dingell, Stupak Applaud NRC for Eliminating Blanket Secrecy Policy at NRC-licensed Fuel Cycle Plants |
August 24, 2007 |
Dingell, Stupak Question FDA Plan to Outsource Jobs |
August 22, 2007 |
Dingell, Stupak, Melancon Welcome Announcement of New Orleans VA Hospital Reconstruction Site |
August 17, 2007 |
Dingell, Stupak Respond to FDA Decision to Halt Lab Closings |
August 13, 2007 |
Dingell, Stupak Praise Tyson Foods for Ceasing Sale of Meat Treated with Carbon Monoxide
|
August 9, 2007 |
Dingell, Stupak Announce Hearing on Biosafety Labs; Committee to Examine Risks Associated with Labs |
August 7, 2007 |
Dingell, Stupak Question Appointment of Commerce Department Acting Inspector General |
August 3, 2007 |
Dingell Releases Draft Legislation to Improve Safety of Imported Food and Drugs |
July 26, 2007 |
Dingell Salutes First FERC Case Using New Anti-Manipulation Authority |
July 25, 2007 |
Dingell, Stupak Respond to Attempted Retaliation Against Congressional Witnesses by Food and Drug Administration Official |
July 17, 2007 |
Dingell, Stupak Praise Safeway, Inc. for Ceasing Sale of Meat Treated with Carbon Monoxide |
June 29, 2007 |
Dingell, Stupak Welcome New DOE Disclosure Policy |
June 29, 2007 |
Dingell, Stupak Commend Increase of FDA Chinese Seafood Inspection, Demand Greater FDA Accountability in Protecting American Food Supply |
June 28, 2007 |
Dingell, Stupak Question FDA Lab Closings |
June 26, 2007 |
Dingell, Stupak Open Investigation into Safety of Meat Treated with Carbon Monoxide; Demand Answers from Safeway, Meat Packers |
June 8, 2007 |
Dingell, Stupak Respond to Frazier Resignation |
May 24, 2007 |
Dingell, Stupak Not Satisfied With FDA Response to Committee Requests; Will Consider Other Options to Fulfill Requests |
May 24, 2007 |
Committee Launches Investigation into Long Term Care Insurance
Read the letters from Dingell and Stupak to Conseco, Inc. and Penn Treaty American Corp. |
May 21, 2007 |
Dingell, Stupak Question FDA & Glaxo for Failing to Warn Diabetics of Dangers of Avandia |
May 2, 2007 |
BP Withheld Key Documents from Committee; Thursday Hearing Postponed to May 16
read the letter » |
May 2, 2007 |
Committee Opens Investigation into Allegations Of Misconduct by Commerce IG
|
April 30, 2007 |
Contamination of Chinese Wheat Gluten Widespread Dingell, Stupak Dispatch Investigators to West Coast Ports
|
April 17, 2007 |
Subcommittee on Oversight and Investigations Will Hold Hearing on Mismanagement at Los Alamos National Labs |
April 11, 2007 |
Committee Asks HHS to Study Doctors' Long Work Hours, Medical Errors
read the letter » |
April 2, 2007 |
GAO Warns that Efforts to Protect Nuclear Materials in Russia Must Be Sustained
read the GAO Report » |
March 30, 2007 |
HHS Inspector General to Reopen NIH Conflict-of-Interest Cases
read letter from the HHS Inspector General » |
March 22, 2007 |
Committee Releases Leavitt Response to Concerns About Health Care Crisis in New Orleans
read response from HHS Secretary Leavitt » |
March 21, 2007 |
Dingell, Stupak Call on Amgen, Johnson & Johnson to Suspend Direct-to-Consumer Marketing for Anemia Drugs
read the letter to Amgen Inc. »
read the letter to Johnson & Johnson » |
March 20, 2007 |
CSB, Baker Commission Reports Confirm BP Cost-Cutting Jeopardized Worker Safety; Dingell to Hold Hearings on BP Lessons Learned Following Prudhoe Bay Spill, Field Shut Down, Recent Reports |
March 14, 2007 |
"GAO Report Highlights Incomplete Research by Government on the Risk from Attacks on LNG Tankers; Dingell and Barton Announce Hearings on LNG Tanker Security Safety and Licensing"
read the GAO Report » |
January 22, 2007 |
"Energy and Commerce Requests Information from FDA on Contract"
read Letter to Food and Drug Administration » |
January 22, 2007 |
Panel Seeks Answers on Nuclear, Cyber Security; Letters to Homeland Security Department, GAO
read Letter to Government Accountability Office »
read Letter to Department of Homeland Security » |
|
September 12, 2008 |
Letter to Wyeth on Multivitamin that Claims to lower cholesterol |
September 2, 2008 |
Letter to Schering-Plough and Merck on Vytorin-Cancer Link
Read the Report on the Simvastatin
and
Ezetimibe in Aortic Stenosis (SEAS) Study » |
August 21, 2008 |
Letter to HHS Secretary Leavitt regarding opposition to HHS approving Rhode Island Medicaid Waiver |
August 21, 2008 |
Letter to companies Schering-Plough and Merck & Company regarding the safety of Vytorin and Conflicting Study Data |
August 8, 2008 |
Letter to GAO Acting Comptroller General Gene Dodaro on Highly Enriched Uranium (HEU) stockpiles around the world |
July 31, 2008 |
Letter to the head of Wyeth Pharmaceuticals regarding a clinical trial being conducted in Ghana to test whether moxidectin can inhibit the production of the parasite associated with river blindness |
July 22, 2008 |
Letter to FDA Commissioner von Eschenbach in regard to drugs sold in the U.S. by Ranbaxy, Inc. |
June 25, 2008 |
Letter to U.S. Government Accountability Office Acting Comptroller General Dodaro regarding Security at Lawrence Livermore Nuclear Lab |
June 17, 2008 |
Letter to the Commodity Futures Trading Commission regarding energy speculation
|
June 4, 2008 |
Letter to Energy Northwest Chief Executive Officer Parrish in regard to the re-enrichment of the Department of Energy's depleted uranium tails
|
May 22, 2008 |
Letter to U.S. government Accountability Office Acting Comptroller General Dodaro regarding a proposed Agreement for Cooperation for the review requirements under Section 123 of the Atomic Energy Act of 1954
Attachment » |
May 20, 2008 |
Letter to the CEOs of five companies regarding direct-to-consumer advertising
Johnson & Johnson »
Merck & Co., Inc. »
Pfizer, Inc. »
PhRMA »
Schering-Plough Corporation »
|
May 8, 2008 |
Letter to 49 Multinational Food Processors about Contamination
Read Recall List » |
May 7, 2008
|
Letter to President Bush: Address Proliferation Concerns before Sending Russian Nuclear Pact to Congress
|
May 6, 2008 |
Letter to four companies requesting voluntary removal of Bisphenol A in products intended for use by infants and children
|
May 1, 2008 |
Letter to the presidents and CEOs of 10 private laboratories regarding to the role of the these labs in ensuring the safety of our Nation's food supply
|
April 30, 2008 |
Letter to the U.S. Government Accountability Office regarding the cost implications of work stoppages at the Hanford Waste Treatment Plant and Tank Farms
|
April 30, 2008 |
Letter to Malt-O-Meal Company President and CEO Neugent in regard to the recall of its cereal due to the risk of potential Salmonella poisoning
|
April 30, 2008 |
Letter to FDA Commissioner von Eschenbach in regard to the recent outbreak of Salmonella associated with cantaloupe from Honduras
|
April 29, 2008 |
Letter to the Committee on Agriculture Chairman Peterson and Ranking Member Goodlatte on Farm Bill Provision to Relocate Plum Island, N.Y., Laboratory to the Mainland
|
April 24, 2008 |
Letter to the Department of Energy regarding impartiality issues
|
April 15, 2008 |
Letter to the Administrator of the U.S. Agency for International Development (USAID) and the Dean of the Johns Hopkins Bloomberg School of Public Health regarding the restriction of scientific inquiry in the Population Information Online (POPLINE) database
Letter to USAID »
Letter to Johns Hopkins University » |
April 11, 2008 |
Letter to the CEOs of Schering-Plough Corporation and Merck & Co, Inc., requesting additional information about the ENHANCE study trial
Read the Attachments » |
April 4, 2008 |
Letter to Food and Drug Administration Commissioner von Eschenbach requesting information regarding the use of Bisphenol A in consumer products |
April 2, 2008 |
Letter to American Chemistry Council President and CEO Gerard in regard to the use of consulting firms to manipulate public opinion related to the use of Bisphenol A and other chemicals |
March 27, 2008 |
Letter to CDC Director Gerberding regarding the treatment of "whistleblower" employees involved in the Great Lakes Report and other studies |
March 26, 2008 |
Letters to the U.S. Government Printing Office in regard to the distribution of our Nation's new e-Passports
read the letter to Inspector General Ogden »
read the letter to Public Printer Tapella » |
March 12, 2008 |
Letter to Attorney General Mukasey in regard to the plea agreement reached with British Petroleum (BP) |
March 12, 2008 |
Letter to FCC Chairman Martin requesting further information about the management practices at the Agency |
March 11, 2008 |
Letter to Homeland Security Secretary Chertoff requesting public release of the Homeland Security Institute's review of Advanced Spectroscopic Portal monitor development |
March 6, 2008 |
Letter to William Nelson requesting further information regarding his e-mail sent to the Committee, his EPFX biofeedback device, and the Eclosion company |
March 5, 2008 |
Letter to HHS Secretary Leavitt in regard to the Agency's offer to access records related to Dr. von Eschenbach's testimony before the Committee March 22, 2007 |
March 1, 2008 |
Letter to EPA Administrator Johnson in regard to industry's use of Bisphenol A |
February 28, 2008 |
Chairmen Dingell and Stupak write CDC Director Gerberding in regard to the withholding of a study entitled Public Health Implications of Hazardous Substances in the Twenty-Six U.S. Great Lakes Areas of Concern |
February 27, 2008 |
Letter to HHS Secretary Leavitt in regard to the Committee's subpoena of hearing documents used to brief Dr. Andrew von Eschenbach |
February 21, 2008 |
Letter to Homeland Security Secretary Chertoff in regard to the Agency's plans to close and relocate operations at the Plum Island Animal Disease Center |
February 21, 2008 |
Letter to FDA Commissioner von Eschenbach requesting documents and information relating to the FDA's foreign inspection program and the drug Heparin |
February 21, 2008 |
Letter to HHS Secretary Leavitt requesting documents and information relating to the FDA's foreign inspection program and the drug Heparin |
February 21, 2008 |
Letter to Baxter International Inc. requesting documents and information relating to the FDA's foreign inspection program and the drug Heparin |
February 14, 2008 |
Letter to FDA Commissioner von Eschenbach in regard to a Chinese facility which produces a drug that has been associated with hundreds of adverse events
April 24, 2008 response » |
February 11, 2008 |
Letter to FDA Commissioner von Eschenbach requesting information that relates to the Agency's protocal approval for the ENHANCE clinical trial |
February 11, 2008 |
Letter to Schering-Plough Corporation and Merck and Co., Inc. requesting additional information from a prior information request regarding the ENHANCE clinical trial |
February 11, 2008 |
Letters to four companies regarding the withholding of clinical trial data during the ENHANCE trial
Letter to Softlayer Technologies, Inc. and Cafepharma Inc. »
Letter to Schering-Plough Corporation
and Merck and Co., Inc. » |
February 6, 2008 |
Letter to Energy Secretary Bodman concerning Department of Energy funding of Russian institutes which are also providing support to the Buhsher nuclear power plant in Iran
read Russian power point slides
(referenced in the letter)
Attachment 1 »
Attachment 2 » |
February 5, 2008 |
Letter to The Weinberg Group CEO Weinberg in regard to an ongoing investigation into the use of the chemical Bisphenol A in products intended for use by children |
January 24, 2008 |
Letter to Schering-Plough Corporation and Merck & Co., Inc. in regard to the witholding of clinical data during the ENHANCE trial |
January 24, 2008 |
Letter to American College of Cardiology CEO Lewin in regard to the witholding of clinical data during the ENHANCE trial |
January 24, 2008 |
Letter to American Heart Association CEO Wheeler in regard to the witholding of clinical data during the ENHANCE trial |
January 22, 2008 |
Letter to Health and Human Services in regard to the Committee's ongoing investigation into Vytorin and the ENHANCE trial |
January 22, 2008 |
Letter to Schering-Plough Corporation and Merck and Co., Inc. in regard to the Committee's ongoing investigation into Vytorin and the ENHANCE trial |
January 18, 2008 |
Letter to Soma Beverage Company, LLC President and CEO Lowe in regard to the recent recall of Metromint bottled water |
January 16, 2008 |
Letter to GAO Comptroller General Walker requesting more information on a possible third class of "Behind-the-Counter" drugs |
January 16, 2008 |
Letter to Schering-Plough Corporation and Merck and Co., Inc. in regard to concerns about misleading stataments in Direct-to-Consumer advertisements of prescription drugs |
January 16, 2008 |
Letter to FDA Commissioner von Eschenbach in regard to concerns about misleading statements in Direct-to-Consumer advertisements of prescription drugs |
January 7, 2008 |
Letter to CEO and Chairman of the Board Kindler of Pfizer, Inc., in regard to Dr. Robert Jarvik's endorsement of the drug Lipitor
read the February 25, 2008 response » |
December 13, 2007 |
Letter to the Texas Applied Biomedical Services and the Biomedical Research Institute of America in regard to the potential misuse of Institutional Review Boards to conduct biomedical research |
December 13, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to the potential misuse of Institutional Review Boards to conduct biomedical research |
December 11, 2007 |
Letter to Schering-Plough Corporation and Merck & Co., Inc. in regard to the witholding of clinical trial data |
December 5, 2007 |
Letter to EPA Administrator Johnson in regard to concerns about the transparency and openness of the Agency's business |
November 9, 2007 |
Letter to HHS Inspector General Levinson in regard to an investigation of several ethics violations at the FDA |
November 9, 2007 |
Letter to Office of Management and Budget Director Nussle in regard to implementation of a law to protect Americans living near nuclear plants |
November 2, 2007 |
Letter to staff at the Department of Homeland Security in regard to the deployment of the Advanced Spectroscopic Portals |
October 23, 2007 |
Letter to the directors of the National Institutes of Health and the National Cancer Institute in regard to potential conflicts of interest that could damage the reputations of the organizations |
October 15, 2007 |
Chairman Stupak and Ranking Member Whitfield write OMB Director Nussle in regard to the National All Schedules Prescription Electronic Reporting Act (NASPER) |
October 12, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to observations from a Committee staff trip to India and China |
October 11, 2007 |
Letter to EPA Administrator Johnson in regard to a recent Washington Post article which highlights the Administration's failure to initiate criminal prosecutions when they are merited |
October 4, 2007 |
Letter to GAO Comptroller General Walker in regard to an investigation of the efficiency and effectiveness of the Government agencies within the Committee's jurisdiction |
October 1, 2007 |
Letter to Centers for Disease Control and Prevention Director Gerberding regarding the Oversight Subcommittee's investigation into the human health consequences of antimicrobials administered to food animals |
Sept. 21, 2007 |
Letter urging Homeland Security Secretary Chertoff to delay certification of Advanced Spectroscopic Portals |
Sept. 20, 2007 |
Letter to Homeland Security Secretary Chertoff in regard to an investigation of operations at the Plum Island Animal Disease Center |
Sept. 20, 2007 |
Letter to Department of Agriculture Acting Secretary Conner in regard to an investigation of operations at the Plum Island Animal Disease Center |
Aug. 24, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to the agency's plans to outsource hundreds of FDA jobs to private companies |
Aug. 13, 2007 |
Letter to HHS Secretary Leavitt in regard the agency's cooperation for a GAO evaluation of security at biosafety laboratories |
Aug. 13, 2007 |
Letter to Robert's American Gourmet Food, Inc. in regard to Salmonella contamination in Veggie Booty snack food |
Aug. 13, 2007 |
Letter to Naval Inspector General Route in regard to contracting issues related to the Office of Naval Research |
Aug. 13, 2007 |
Letter to Total Nonstop Action Wrestling President Carter in regard to illegal steroid use in pro wrestling |
Aug. 13, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to an FDA investigation of the Cordis Corporation's Coronary Stent |
Aug. 10, 2007 |
Letter to Homeland Security Under Secretary for Management Paul Schneider in regard to the Department's ability to prevent nuclear attacks
Read the August 20, 2007 letter » |
Aug. 7, 2007 |
Letter to Homeland Security Secretary Chertoff in regard to the adequacy of that Department's biosurveillance efforts |
Aug. 7, 2007 |
Letter to Department of Commerce Secretary Gutierrez in regard to the Appointment of Commerce Department Acting Inspector General |
Aug. 2, 2007 |
Letter to American Superconductor Corporation President and CEO, Yurek in regard to a contract awarded to the AMSC by the Department of Homeland Security |
Aug. 2, 2007 |
Letter to Richard Blum, University of California Chairman of the Regents, in regard to the University's request to DOE to consider that the Eleventh Amendment bars Federal Government enforcement action due to immunity from lawsuits |
Aug. 1, 2007 |
Letter to GAO Comptroller General David Walker in regard to the FDA's ability to ensure the safety of the Nation's drug supply |
Aug. 1, 2007 |
Letter to DOE Secretary Bodman in regard to a $9.5 billion non-competitive decontamination contract proposal |
July 31, 2007 |
Letter to FDA Commissioner von Eschenbach with concerns about the consequences of FDA contracting out surveillance sampling, as well as other FDA food sampling, to private laboratories |
July 25, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to retaliation against FDA witnesses
Read July 19, 2007 e-mail » |
July 13, 2007 |
Letter to EPA Administrator Johnson in regard to the ongoing investigation of the drinking water contamination at Camp Lejeune |
July 13, 2007 |
Letter to EPA Administrator Johnson in regard to the adequacy of the criminal enforcement program |
July 6, 2007 |
Letter to Homeland Security Secretary Chertoff in regard to contracts awarded to American Superconductor Corporation and Consolidated Edison Group |
July 6, 2007 |
Letter to Department of Navy Assistant Secretary of the Navy for Research, Etter in regard to a Committee evaluation of the contracts awarded to the American Superconductor Corporation |
July 3, 2007 |
Letter to U.S. Nuclear Regulatory Commission Chairman Klein in regard to a major nuclear safety event and the release of documents relating to the event
read the June 7, 2007 NRC letter » |
June 26, 2007 |
Letter to Department of Energy Secretary Bodman requesting documents in regard to the Radiological and Environmental Sciences Laboratory in Idaho |
June 26, 2007 |
Letter to Tyson Foods, Inc. in regard to the safety of meat treated with carbon dioxide
read the August 9, 2007 response » |
June 26, 2007 |
Letter to Safeway, Inc. in regard to the safety of meat treated with carbon dioxide
Ready July 16, 2007 letter from Safeway, Inc. » |
June 26, 2007 |
Letter to Pactiv Corporation in regard to the safety of meat treated with carbon dioxide |
June 26, 2007 |
Letter to Hormel Foods Corporation and Cargill Incorporated in regard to the safety of meat treated with carbon dioxide |
June 15, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to proposed closure of FDA laboratories |
June 15, 2007 |
Letter to HHS Secretary Leavitt in regard to risks associated with certain prescription drugs known as EPO products
read the September 27, 2007 response » |
June 14, 2007 |
Letter to Department of Energy Secretary Bodman in regard to a recent security incident at the Los Alamos National Laboratory (LANL) |
June 6, 2007 |
Letter to Under Secretary for Food Safety Raymond in regard to the safety of food imports from China |
June 6, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to FDA consultant Douglas Arbesfeld's critique of an Avandia study published by Dr. Steven Nissen
read the June 7, 2007 letter from
Senate and House members » |
June 5, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to the FDA's ability to protect the safety of the Nation's food supply |
May 24, 2007 |
Letter to HHS Secretary Leavitt in regard to problems associated with the operation of the FDA |
May 23, 2007 |
Letter to the GAO comptroller general asking him to review matters relating to a legislative proposal by USEC Inc., to transfer uranium inventories from DOE to the corporation |
May 11, 2007 |
Letter to BP America Chairman and President Malone in regard to the ongoing investigation of the leak incidents on the Prudhoe Bay Oil Transit Lines |
May 4, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to the safety of Avandia |
April 30, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to an investigation into post-marketing drug safety |
April 30, 2007 |
Letter BP Chairman and President Malone, in regard to the pending investigation of the cost-cutting atmosphere at BP's Prudhoe Bay facility |
April 18, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to the FDA's ability to protect human and farm animal health from the risks associated with prescription drugs |
April 13, 2007 |
Letter to EPA Administrator Johnson in regard to an inquiry into EPA expenditures for the Performance Track program |
April 12, 2007 |
Letter to FCC Chairman Martin in regard to the Committee's investigation into the Universal Service Fund |
April 12, 2007 |
Letter to GAO Comptroller General Walker in regard to an inquiry into the FCC's management of the Universal Service Fund |
April 10, 2007 |
Letter to US Consumer Product Safety Commission Acting Chairman Nord requesting action to improve the safety of free-standing kitchen ranges |
April 3, 2007 |
Letter to DOE Secretary Bodman requesting documents for an evaluation of the Radiological and Environmental Sciences Laboratory |
March 30, 2007 |
Letter to FDA Commissioner Andrew von Eschenbach requesting documents for an investigation into the recent contamination of pet food |
March 29, 2007 |
Letter to HHS Acting Director Munier in regard to continued cooperation and assistance into preventable medical errors associated with caregiver work schedules
read the response |
March 28, 2007 |
Letter to Secretary Leavitt in regard to Commissioner Andrew von Eschenbach's appearance before the Subcommittee on Oversight and Investigations on March 22, 2007 |
March 27, 2007 |
Letter to Senators Bingaman, Domenici, Dorgan and Udall regarding the GAO's investigation of Los Alamos National Laboratory |
March 20, 2007 |
Letter to Amgen in which Chairmen Dingell and Stupak call on the company to suspend direct-to-consumer marketing for anemia drugs
read the April 18, 2007 response » |
March 20, 2007 |
Letter to Johnson & Johnson in which Chairmen Dingell and Stupak call on the company to suspend direct-to-consumer marketing for anemia drugs
read theApril 18, 2007 response »
read the August 10, 2007 response » |
March 9, 2007 |
Letter to Sanofi-Aventis chairman Timothy Rothwell regarding the the circumstances surrounding the FDA approval of the Sanofi-Aventis antibiotic Ketek |
March 8, 2007 |
Letter to HHS Secretary Leavitt regarding investigation into allegations of apparent conflicts of interest in the Food and Drug Administration contracting practices involving the former Director of the Office of Information Technology |
March 6, 2007 |
Letter to ConAgra Foods, Inc., regarding the Committee's investigation into the safety of the Nation's food supply and the recent outbreak of salmonella contamination in peanut butter produced by ConAgra |
March 5, 2007 |
Letter to Acting Chairman Nancy A. Nord, Consumer Product Safety Commission, regarding the stability of free-standing kitchen ranges sold and installed in the U.S., including repots that serious injuries and even deaths may have been caused by kitchen ranges tipping over onto small children |
February 28, 2007 |
Letter to Department of Homeland Security Secretary Chertoff regarding the Committee's investigation into illegal activity over the Internet |
February 27, 2007 |
Letter to Treasury Secretary Paulson regarding the Committee's inquiry into illegal activity over the Internet |
February 27, 2007 |
Letters to Platinum Solutions, Inc. and ProObject, Inc. regarding the Committee's investigation of possible conflicts of interest in contracting at the U.S. Food and Drug Administration
read the Letter to Platinum Solutions »
read the Letter to ProObject, Inc. » |
February 27, 2007 |
Letters to Copernicus Group, IRB and PPD, Inc., regarding the Committee's inquiry into the adequacy of the efforts of the U.S. FDA to protect the American public from excessive risks from prescription drugs, including the circumstances surrounding the Sanofi-Aventis antibiotic Ketek
read the Letter to Copernicus Group, IRB »
read the Letter to PPD, Incorporated » |
February 16, 2007 |
Letter to U.S. Comptroller General Walker requesting the assistance of GAO in developing and implementing options to solve the problems, including security failures, at the Los Alamos National Laboratory |
February 16, 2007 |
Letter to HHS Secretary Leavitt requesting documents and information related to the Committee's investigation of pre-market review and post-market surveillance of the antibiotic telithromycin (Ketek) |
February 15, 2007 |
Letter to FDA Commissioner von Eschenbach regarding the recent major outbreak in the United States of salmonella in peanut butter |
February 6, 2007 |
Letter to FDA Commissioner von Eschenbach regarding FDA contemplating a shut down of 7 to 9 of the 13 laboratories that the FDA operates, including the Forensic Chemistry Lab |
February 5, 2007 |
Letter to HHS Secretary Leavitt regarding HHS's newly-announced plan to improve the healthcare delivery system in the Gulf Region affected by Hurricane Katrina |
January 29, 2007 |
Letter to FDA Commissioner von Eschenbach regarding the Committee's investigation into the adequacy of the efforts of the FDA to protect the safety of the Nation's food supply |
January 29, 2007 |
Letter to FDA Commissioner von Eschenbach regarding the Committee's inquiry regarding the adequacy of the generic drug approval process at the FDA |
January 19, 2007 |
Letter to the Department of Homeland Security's Director of the Domestic Nuclear Detection Office asking for information regarding the efforts of the DNDO to test and deploy nuclear detection technologies |
January 19, 2007 |
Letter to Comptroller General Walker requesting a review of the Department of Energy's cyber security programs and provide a report |
January 19, 2007 |
Letter to SEC Chairman Cox regarding the ongoing Hewlett-Packard investigation and H-P CEO Hurd's insider-trading response |
|
July 31, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, “The Recent Salmonella Outbreak: Lessons Learned and Consequences to Industry and Public Health.” |
July 24, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, “Long-Term Care Insurance: Are Consumers Protected for the Long Term?” |
June 23, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Subcommittee hearing entitled, “Energy Speculation: Is Greater Regulation Necessary to Stop Price Manipulation? – Part II” |
June 12, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing entitled, “American Lives Still at Risk: When Will FDA’s Food Protection Plan Be Fully Funded and Implemented?” |
May 29, 2008
|
Dingell, Stupak on CFTC Energy Futures Trading Proposal
|
May 22, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "Germs, Viruses and Secrets: Government Plans to Move Exotic Disease Research to the Mainland United States" |
May 15 , 2008 |
Chairman Dingell, Subcommittee on Oversight and Investigations Hearing entitled "In the Hands of Strangers: Are Nursing Home Safeguards Working?” |
May 8 , 2008 |
Chairman Dingell, Subcommittee on Oversight and Investigations Hearing entitled, "Direct-to-Consumer Advertising: Marketing, Education or Deception?” |
April 29, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "The Heparin Disaster: Chinese Counterfeits and American Failures" |
April 22, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "FDA’s Foreign Drug Inspection Program: Weaknesses Place Americans at Risk" |
April 3, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "Selling the Department of Energy's Depleted Uranium Stockpile: Opportunities and Challenges" |
March 12, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "Regulatory Failure: Must America Live with Unsafe Food?" |
February 26, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing titled, "Contaminated Food: Private Sector Accountability" |
February 12, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "Ketek Clinical Study Fraud: What Aventis Knew" |
January 29, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing entitled, "Science and Mission at Risk: FDA's Self-Assessment" |
January 23, 2008 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing entitled, "Combating Nuclear Proliferation: The Effectiveness of the Department of Energy's Initiatives for Proliferation Prevention (IPP) Program" |
December 12, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing entitled, "Energy Speculation: Is Greater Regulation Needed to Stop Price Manipulation?" |
December 11, 2007 |
Dingell, Stupak on HHS Agreement on Food and Drug Safety Imports |
Nov. 13, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing Entitled "Diminshed Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply? - Part IV - Deception in Labeling"
|
Nov. 1, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing Entitled, "FDA Foreign Drug Inspection Program: A System At Risk" |
Oct. 24, 2007 |
Chairman Dingell, Subcommittee on Oversight and Investigations Hearing entitled “NASPER: Why Has the National All Schedules Prescription Electronic Reporting Act Not Been Implemented?” |
Oct. 11, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing entitled "Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply? - Part III" |
Oct. 4, 2007 |
Chairman Dingell, Subcommittee on Oversight and Investigations hearing entitled "Germs, Viruses, and Secrets: The Silent Proliferation of Bio-Research Laboratories in the United States" |
Sept. 18, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing Entitled "Nuclear Terrorism Prevention: Status Report on the Federal Government's Assessment of New Radiation Detection Monitors" |
Aug. 1 , 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing Entitled "Post-Katrina Health Care in the New Orleans Region: Progress and Continuing Concerns - Part II" |
July 17, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply? - Part 2" |
June 26, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Predatory Sales Practices in Medicare Advantage" |
June 12, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Poisoned Patriots: Contaminated Drinking Water at Camp Lejeune" |
May 22, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing on "Gasoline Prices, Oil Company Profits, and the American Consumer" |
May 16, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "2006 Prudhoe Bay Shutdown: Will Recent Regulatory Changes and BP Management Reforms Prevent Future Failures?" |
April 24, 2007 |
Statement of the Honorable John D. Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply?" |
April 20, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "The Department of Energy's Response to Ongoing Mismanagement at the Los Alamos National Labs" |
March 22, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "The Adequacy of the FDA Efforts to Assure the Safety of the Drug Supply Part II" |
March 13, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Post Katrina Health Care: Continuing Concerns and Immediate Needs in the New Orleans Region" |
February 13, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply" |
January 30, 2007 |
Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Continuing Security Concerns at Los Alamos National Laboratory" |
|
Note: If you would like to view materials released by other Members of the Committee, click here to link to their home pages.
To read these documents, you must have Adobe Acrobat Reader software installed on your computer. Click on the icon below to download this software for free if you do not have it already installed.
|
|